News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current CEL market cap is 39.26M. The company's latest EPS is GBP -0.1082 and P/E is -5.50.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 0 | 24k | 149k |
| Operating Income | -206k | -187k | -722k | -13.51M | -6.96M |
| Net Income | -191k | -175k | -720k | -17.01M | -7.14M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 5.66M | 5.5M | 6.61M | 13.25M | 9.22M |
| Total Liabilities | 33k | 42k | 197k | 6.21M | 6.04M |
| Total Equity | 5.63M | 5.46M | 6.41M | 7.04M | 3.18M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -174k | -160k | -2.71M | -6.1M | -5.97M |
| Investing | N/A | N/A | N/A | 1.39M | -341k |
| Financing | 5.82M | N/A | 1.68M | 5.95M | 2.51M |
| Market Cap | 39.26M |
| Price to Earnings Ratio | -5.50 |
| Price to Sales Ratio | 258.7 |
| Price to Cash Ratio | 31.15 |
| Price to Book Ratio | 12.34 |
| Dividend Yield | - |
| Shares Outstanding | 65.98M |
| Average Volume (1 week) | 98.8k |
| Average Volume (1 Month) | 45.6k |
| 52 Week Change | -60.33% |
| 52 Week High | 150.00 |
| 52 Week Low | 56.00 |
| Spread (Intraday) | 5 (8.06%) |
| Company Name | Celadon Pharmaceuticals Plc |
| Address |
32-33 cowcross street london EC1M 6DF |
| Website | https://celadonpharma.co.uk |
| Industry | investment advice (6282) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
